Product details
Background:Cibotercept is an anti-MSTN/INHBA/GDF11 monoclonal antibody.
• LncRNA ACVR2B-as1 interacts with ALDOA to regulate the self-renewal and apoptosis of human spermatogonial stem cells by controlling glycolysis activity., PMID:39254854
• Epistasis between polymorphisms in ACVR2B and ADAMTS19 is associated with premature ovarian failure., PMID:25051287
• ACVR2B/Fc counteracts chemotherapy-induced loss of muscle and bone mass., PMID:29089584
• Activin A and Acvr2b mRNA from Umbilical Cord Blood Are Not Reliable Markers of Mild or Moderate Neonatal Hypoxic-Ischemic Encephalopathy., PMID:33706404
• Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B., PMID:26047946
• iMSC-mediated delivery of ACVR2B-Fc fusion protein reduces heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva., PMID:38500216
• BMPR2 inhibits activin and BMP signaling via wild-type ALK2., PMID:29739878
• Circ_0000566 contributes oxygen-glucose deprivation and reoxygenation (OGD/R)-induced human brain microvascular endothelial cell injury via regulating miR-18a-5p/ACVR2B axis., PMID:36781583
• Muscle and serum metabolomes are dysregulated in colon-26 tumor-bearing mice despite amelioration of cachexia with activin receptor type 2B ligand blockade., PMID:30860875
• Antibody-based strategies for the detection of Luspatercept (ACE-536) in human serum., PMID:28929587






